| MeSH term | MeSH ID | Detail |
|---|---|---|
| Heart Failure | D006333 | 36 associated lipids |
| Arthritis, Rheumatoid | D001172 | 3 associated lipids |
| Osteitis | D010000 | 10 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| Osteolysis | D010014 | 8 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Osteoarthritis, Hip | D015207 | 4 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kobayashi-Sakamoto M et al. | NF-kappaB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15013432 |
| MacQuarrie RA et al. | Wear-particle-induced osteoclast osteolysis: the role of particulates and mechanical strain. | 2004 | J. Biomed. Mater. Res. Part B Appl. Biomater. | pmid:15015218 |
| O' Gradaigh D et al. | Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. | 2004 | Ann. Rheum. Dis. | pmid:15020327 |
| Lowe CE et al. | Cost-effective analysis of candidate genes using htSNPs: a staged approach. | 2004 | Genes Immun. | pmid:15029236 |
| Ishii T et al. | Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15033472 |
| Suda T and Miyaura C | [Recent advance in basic research for osteoporosis]. | 2004 | Nippon Rinsho | pmid:15035090 |
| Matsumoto T | [Recent advances in the regulation of bone remodeling]. | 2004 | Nippon Rinsho | pmid:15035093 |
| Okumura S et al. | [Regulatory mechanism of osteoclast differentiation and function]. | 2004 | Nippon Rinsho | pmid:15035103 |
| Udagawa N et al. | [Possible role of RANKL in bone resorption]. | 2004 | Nippon Rinsho | pmid:15035104 |
| Inoue D | [OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)]. | 2004 | Nippon Rinsho | pmid:15035105 |
| Suzuki Y | [Stimulator of bone resorption interleukin-1, interleukin-6 and gp-130 cytokine family]. | 2004 | Nippon Rinsho | pmid:15035106 |
| Miyaura C | [LPS]. | 2004 | Nippon Rinsho | pmid:15035108 |
| Tanaka Y | [Adhesion molecules in the context with bone remodeling and osteoporosis]. | 2004 | Nippon Rinsho | pmid:15035110 |
| Tomoyasu A and Higashio K | [Osteoclastogenesis inhibitory factor/osteoprotegerin(OCIF/OPG)]. | 2004 | Nippon Rinsho | pmid:15035190 |
| Sohen S | [Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases]. | 2004 | Nippon Rinsho | pmid:15035207 |
| Tanaka Y | [Secondary osteoporosis due to systemic autoimmune diseases and rheumatic diseases]. | 2004 | Nippon Rinsho | pmid:15035208 |
| Fukunaga J and Sugahara T | [Osteoporosis induced by immunosuppressant]. | 2004 | Nippon Rinsho | pmid:15035219 |
| Juji T and Tanaka S | [Novel therapeutic approach to bone metabolic disorders using RANKL vaccination]. | 2004 | Nippon Rinsho | pmid:15035230 |
| Eaton CL et al. | Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer. | 2004 | Prostate | pmid:15042606 |
| Brown JM et al. | Opg, RANKl, and RANK in cancer metastasis: expression and regulation. | 2004 | Cancer Treat. Res. | pmid:15043192 |
| Tay JY et al. | Identification of RANKL in osteolytic lesions of the facial skeleton. | 2004 | J. Dent. Res. | pmid:15044512 |
| Doran PM et al. | Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts. | 2004 | Exp. Hematol. | pmid:15050745 |
| Kostenuik PJ et al. | Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. | 2004 | Bone | pmid:15050896 |
| Gonzalez-Calvin JL et al. | Bone mineral density and serum levels of estradiol and osteoprotegerin in postmenopausal women with viral cirrhosis. | 2004 | Gastroenterology | pmid:15057779 |
| Cheng Q et al. | [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women]. | 2004 | Zhonghua Yi Xue Za Zhi | pmid:15059506 |
| Pritzker LB et al. | The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. | 2004 | Mol. Biol. Cell | pmid:15064358 |
| Salmon P | Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone. | 2004 | J. Bone Miner. Res. | pmid:15068491 |
| Morabito N et al. | Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. | 2004 | J. Bone Miner. Res. | pmid:15068494 |
| Kim HH et al. | Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. | 2004 | Biochem. Pharmacol. | pmid:15081864 |
| Kyrtsonis MC et al. | Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease. | 2004 | Eur. J. Haematol. | pmid:15089762 |
| Miao D et al. | Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice. | 2004 | Endocrinology | pmid:15090463 |
| Pulsatelli L et al. | Soluble receptor activator of nuclear factor- kappaB Ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases. | 2004 | Biogerontology | pmid:15105586 |
| Hofbauer LC et al. | Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid. | 2004 | Acta Neuropathol. | pmid:15106011 |
| Suzuki T et al. | Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NFKappa-B ligand (RANKL). | 2004 | J. Bone Miner. Metab. | pmid:15108059 |
| Haynes DR et al. | Regulation of osteoclast activity in peri-implant tissues. | 2004 | Biomaterials | pmid:15109848 |
| Ito S and Hata T | Crystal structure of RANK ligand involved in bone metabolism. | 2004 | Vitam. Horm. | pmid:15110169 |
| Hao C et al. | Modulation of TRAIL signaling complex. | 2004 | Vitam. Horm. | pmid:15110173 |
| Kiechl S et al. | Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. | 2004 | Circulation | pmid:15117849 |
| Yeung RS | The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss. | 2004 | J. Rheumatol. | pmid:15124240 |
| Masi L et al. | Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury? | 2004 | J. Rheumatol. | pmid:15124262 |
| Nitta K et al. | Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. | 2004 | Nephrol. Dial. Transplant. | pmid:15128884 |
| Milstead JR et al. | Spaceflight and hindlimb suspension disuse models in mice. | 2004 | Biomed Sci Instrum | pmid:15133943 |
| Karst M et al. | Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. | 2004 | J. Cell. Physiol. | pmid:15137062 |
| Emanuele E et al. | Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease. | 2004 | Int. J. Mol. Med. | pmid:15138623 |
| Jang HD et al. | PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit. | 2004 | J. Biol. Chem. | pmid:15140884 |
| Granet C et al. | Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. | 2004 | Arthritis Res. Ther. | pmid:15142264 |
| Bengtsson AK et al. | 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. | 2004 | Blood | pmid:15142882 |
| Golledge J et al. | Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. | 2004 | Stroke | pmid:15143295 |
| Seshasayee D et al. | A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response. | 2004 | J. Biol. Chem. | pmid:15145935 |
| Nishimura K et al. | Effects of irradiation on cementum matrix cytokins function during periodontal regeneration. | 2003 | Hum. Cell | pmid:15147042 |
| Abedin M et al. | Vascular calcification: mechanisms and clinical ramifications. | 2004 | Arterioscler. Thromb. Vasc. Biol. | pmid:15155384 |
| Vidal K et al. | Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. | 2004 | Pediatr. Res. | pmid:15155868 |
| Xiao HL et al. | Expression and identification of mutated osteoprotegerin in culture cells and larvae of silkworm. | 2004 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:15156274 |
| Saidenberg-Kermanac'h N et al. | Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. | 2004 | J. Clin. Immunol. | pmid:15163893 |
| Pioletti DP and Kottelat A | The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. | 2004 | Biomaterials | pmid:15172492 |
| Livshits G et al. | Genetic influences on the circulating cytokines involved in osteoclastogenesis. | 2004 | J. Med. Genet. | pmid:15173242 |
| De Wilde A et al. | A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets. | 2004 | J. Cell. Physiol. | pmid:15174095 |
| Dovio A et al. | [Pathophysiological significance and clinical utility of circulating osteoprotegerin]. | 2004 Jan-Mar | Ann. Ital. Med. Int. | pmid:15176704 |
| Taranta A et al. | Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. | 2004 | J. Bone Miner. Res. | pmid:15176994 |
| Coetzee M and Kruger MC | Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment? | 2004 | South. Med. J. | pmid:15180028 |
| Melhus H | Soluble RANKL and risk of nontraumatic fracture. | 2004 | JAMA | pmid:15187049 |
| Kazama JJ | Osteoprotegerin and bone mineral metabolism in renal failure. | 2004 | Curr. Opin. Nephrol. Hypertens. | pmid:15199291 |
| Walsh NC and Gravallese EM | Bone loss in inflammatory arthritis: mechanisms and treatment strategies. | 2004 | Curr Opin Rheumatol | pmid:15201606 |
| Stilgren LS et al. | Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. | 2004 | Bone | pmid:15207766 |
| Tsangari H et al. | Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. | 2004 | Bone | pmid:15207775 |
| Terpos E et al. | Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma. | 2004 | Leukemia | pmid:15215875 |
| Brändström H et al. | A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). | 2004 | Blood Press. | pmid:15223723 |
| Wilson SE et al. | RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. | 2004 | Invest. Ophthalmol. Vis. Sci. | pmid:15223796 |
| Kang HS et al. | Receptor activator of nuclear factor-kappaB is induced by a rottlerin-sensitive and p38 MAP kinase-dependent pathway during monocyte differentiation. | 2004 | Mol. Cells | pmid:15232218 |
| Bord S et al. | Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. | 2004 | Br. J. Haematol. | pmid:15238146 |
| Buxton EC et al. | Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). | 2004 | J. Clin. Endocrinol. Metab. | pmid:15240611 |
| Kochanowska I et al. | Influence of osteoprotegerin (OPG) on resorption of heterotopically induced ossicle. | 2004 | Cell Tissue Bank | pmid:15241009 |
| Corso A et al. | Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls. | 2004 | Leukemia | pmid:15241438 |
| Harada M et al. | Concentration of osteoprotegerin (OPG) in peritoneal fluid is increased in women with endometriosis. | 2004 | Hum. Reprod. | pmid:15242994 |
| Matsuo K and Ray N | Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology. | 2004 | Keio J Med | pmid:15247511 |
| Mosheimer BA et al. | Expression and function of RANK in human monocyte chemotaxis. | 2004 | Arthritis Rheum. | pmid:15248232 |
| Xu D et al. | Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members. | 2004 | Biochem. J. | pmid:15250821 |
| De Leenheer E et al. | Evidence of a role for RANKL in the development of myeloma bone disease. | 2004 | Curr Opin Pharmacol | pmid:15251126 |
| Jung K et al. | Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. | 2004 | Int. J. Cancer | pmid:15252851 |
| Varga F et al. | Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype. | 2004 | Calcif. Tissue Int. | pmid:15255076 |
| Garlet GP et al. | Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. | 2004 | J. Clin. Periodontol. | pmid:15257746 |
| Baumann B et al. | Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. | 2004 | Acta Orthop Scand | pmid:15260421 |
| Tomek S et al. | Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs. | 2004 | Gynecol. Oncol. | pmid:15262127 |
| Miyashita T et al. | Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells. | 2004 | Clin. Exp. Immunol. | pmid:15270863 |
| Nociti FH et al. | Cementoblast gene expression is regulated by Porphyromonas gingivalis lipopolysaccharide partially via toll-like receptor-4/MD-2. | 2004 | J. Dent. Res. | pmid:15271967 |
| Hashimoto T et al. | [Biochemical markers in bone metastasis]. | 2004 | Gan To Kagaku Ryoho | pmid:15272580 |
| Oh KW et al. | The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women. | 2004 | Clin. Endocrinol. (Oxf) | pmid:15272921 |
| Doi S et al. | Increased serum osteoprotegerin level in older and diabetic hemodialysis patients. | 2004 | Ther Apher Dial | pmid:15274686 |
| Hofbauer LC and Schoppet M | Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. | 2004 | JAMA | pmid:15280347 |
| Kanatani M et al. | Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. | 2004 | J. Cell. Physiol. | pmid:15281085 |
| Farach-Carson MC et al. | Integrating rapid responses to 1,25-dihydroxyvitamin D3 with transcriptional changes in osteoblasts: Ca2+ regulated pathways to the nucleus. | 2004 | Steroids | pmid:15288767 |
| Vanderborght A et al. | Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls. | 2004 | J. Rheumatol. | pmid:15290725 |
| Soufi M et al. | Osteoprotegerin gene polymorphisms in men with coronary artery disease. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15292302 |
| Schoppet M et al. | Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15292354 |
| Lossdörfer S et al. | Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. | 2004 | J Biomed Mater Res A | pmid:15293309 |
| Kahl KG et al. | Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. | 2005 | Osteoporos Int | pmid:15300363 |
| Sato T et al. | Interleukin-11 as an osteoprotegerin-inducing factor in culture medium of blastic cells from a patient with acute megakaryocytic leukemia complicated with osteosclerosis. | 2004 | Am. J. Hematol. | pmid:15307108 |
| Giuliani N et al. | New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL). | 2004 | Exp. Hematol. | pmid:15308315 |
| Colucci S et al. | T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction. | 2004 | Blood | pmid:15308561 |
| Kondo T et al. | 1 alpha,25 dihydroxyvitamin D3 rapidly regulates the mouse osteoprotegerin gene through dual pathways. | 2004 | J. Bone Miner. Res. | pmid:15312241 |